No Picture
Trading Ideas

Drawing a Line Between Our Connections

The greatest form of wealth can’t be inflated away.
As the folks in Washington debate who’s next on their list to get a slug of freshly printed money… and as the stock market shrugs off one of the market’s greatest interruptions ever… it’s time to measure what we have in a different way.
Last Friday, our good pal Mark Ford mused about the idea of working with friends.
It’s a bad idea, he concluded, never to be done again.
We never would have guessed it’d be a controversial topic. Mark’s piece was filled with real-life experience, wisdom and old-fashioned common sense.
But nearly as soon …read more […]

No Picture
Business News

Huawei Meng’s U.S. extradition case hinges on key ruling in Canada on Wednesday

A Canadian judge will rule Wednesday on a key aspect of Huawei Technologies Chief Financial Officer Meng Wanzhou’s extradition to the United States, with a favourable judgment seen as paving the way for the release of the Chinese executive after 18 months of house arrest.

…read more […]

No Picture
Business News

Timeline: Key events in Huawei CFO Meng Wanzhou’s extradition case

A Canadian judge will rule Wednesday on a key aspect of Huawei Technologies Co Ltd’s Chief Financial Officer Meng Wanzhou’s extradition to the United States. The judge will rule on double criminality, meaning whether the charges against Meng were illegal in both Canada and the United States at the time of her December 2018 arrest.

…read more […]

No Picture
Trading Ideas

Regeneron Announces Secondary Offering Pricing At $515/Share

Regeneron Pharma (REGN) has now announced the pricing of the underwritten public secondary offering of 11,831,496 shares of its common stock held by French drugmaker Sanofi at a price of $515 per share.Regeneron has also agreed to purchase 9,806,805 shares directly from Sanofi, at a price of $509.85 per share (representing the price paid by the underwriters in the offering), for an aggregate purchase amount of $5 billion.In connection with the offering, the underwriters have a 30-day option to purchase up to an additional 1,183,150 Regeneron shares from Sanofi, the statement revealed. If the underwriters fully exercise their option to …read more […]